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Summary.-Electron spin resonance studies have been made of caeruloplasmin and
iron transferrin levels in whole blood of healthy controls and patients with a variety
of malignant conditions receiving various forms of treatment.
A small difference was found in caeruloplasmin level between normal males and
females, although normal females receiving contraceptive steroids had an elevated
level. No difference was found in iron transferrin level. Various conditions increased
the caeruloplasmin and some also decreased the iron transferrin level in patients with
malignant disease. These included surgery and the approach of a terminal phase of
disease. Once allowance for these factors was made, the remaining small differences
in Cu and Fe between patients with either squamous cell carcinoma or breast cancer
and controls appeared to have no clinical significance.
VARIATIONS in serum concentrations of
Cu, caeruloplasmin and Fe have been
reported to be associated with a variety of
conditions, e.g. increases in serum Cu
were associated with administration of
oestrogens (Russ and Raymunt, 1956)
Cu level rose and Fe fell in serum of post-
operative patients (Zwicker, 1959) and
serum Cu fell after exposure to ionizing
radiations (Tomas, Cristea and Mocanu,
1972), as did plasma Fe level (O'Shea,
Kershenobich and Tavill, 1973). Serum Cu
rose with inflammation and acute and
chronic infections (Brendstrup, 1953).
Such changes must be considerecl in any
assessment ofthe clinical value ofmeasure-
ments of blood caeruloplasmin and Fe
transferrin level. Hughes (1972), using
radial immunodiffusion, found an increase
in mean serum caeruloplasmin and a
decrease in mean transferrin (as opposed
to Fe transferrin) concentrations in
patients with malignant disease. A study
of electron spin resonanace (ESR) signals
from caeruloplasmin by Swartz and
Wiesner (I1972) showed an increase in
signal size in mixed cancer patients, and a
decrease on response to radiotherapy.
Foster et al. (1973) showed that caerulo-
plasmin (g 2.049) and Fe transferrin
(g , 4.2) levels can be measured by ESR
in whole, frozen blood and that a small
increase in mean size of caeruloplasmin
signal can be detected in patients suffering
from malignant diseases as compared with
healthy controls. A larger-scale investiga-
tion of malignant lymphoma (Foster et al.,
1977a, b) hasshownthatthealready-known
variations in serum Cu with disease
activity in Hodgkin's disease can be
detected by ESR and that these are much
less marked in non-Hodgkin's lymphoma.
Also the ESR-detectable changes in
Hodgkin's disease occurred well before
relapse was clinically detectable.
A further study of changes in caerulo-
plasmin and Fe transferrin levels in other
malignant diseases has now been made,
particularly attempting to analyse extra-
neous factors that might influence the
results, and hence to isolate any variations
which may be due specifically to theT. POCKLINGTON AND M. A. FOSTER
diseases. Also, to provide a basis for
comparison with these results, a survey
has been made of ESR signals in blood of
healthy controls under various conditions.
MATERIALS AND TECHNIQUES
Techniques used for the ESR study of
caeruloplasmin and Fe transferrin in whole
blood are identical to those previously
described (Foster et al., 1977a). Control
samples wNere obtained from 213 healthy
volunteers who attended the blood-donor
sessions of the North of Scotland Blood
Transfusion Service. The samples were re-
moved through the venous insert after blood
for the transfusion service had been with-
drawn. Note was made of the sex and age of
the volunteer and, in the case of women, they
were asked if they were taking contraceptive
steroids, or had done so during the past
month. The samples wAere immediately frozen
and kept in liquid N2 overnight for examina-
tion the next day.
Blood from patients wAith malignant
diseases w%as obtained through the Malignant
Diseases Unit of Aberdeen Royal Infirmary.
The samples were removed by venous
puncture and frozen within 2 min.
Sample tubes were individually calibrated
for cross-sectional area and peak-to-peak
signal heights wAere corrected accordingly. A
sample of 10-4M CuSO4 in saline was
measured several times during the course of
each instrument run and, based on this, a
correction was made for day-to-day machine
variations.
RESULTS AND DISCUSSION
Normal subjects
The range of peak-to-peak heights for
the caeruloplasmin (g 2.049) signal in
males, and in females receiving or not
receiving contraceptive steroids, is shown
in Fig. 1. The difference between males and
normal females is small but significant
(P>0.01) and females receiving contra-
ceptive steroids showed a considerable
increase in mean caeruloplasmin level.
The wider scatter in normal females than
in males may have been due to some
women stating that they were not receiv-
ing contraceptives when, in fact, they
were. The scatter in steroid female
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FiG. 1. Range of values for peak-to-peak
height of caeruloplasmin signal from whole
bloodl of normal males and females, andl
females receiving contraceptive steroids.
results may be due to the variation in
oestradiol dose between different prepara-
tions.
Fig. 2 shows that there is no significant
difference in concentration of Fe trans-
ferrin in blood of males and females. There
is no detectable difference in g 4-2
signal size between those women receiving
steroids (1 075 A 0419, n- 20) and those
who were not (1P059 i 0 403, n 37).
Individual variation was measured over
the course of 16 months. Caeruloplasmin
signal height varied from 0-84 to 1P54
(mean 1P087 ± 0.209), whereas the Fe
transferrin level showed much more varia-
tion, ranging from 0-85 to 2-77 (mean
1 405 i 0.509). Analysis of control data
for changes associated with age is shown
in Table I. The caeruloplasmin level shows
no variation with age in either sex between
18 and 55 years, and then increases slightly
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FIG. 2.-Range of values for peak-to-peak
height of Fe transferrin signal from whole
blood of normal males and females.
in females. The Fe transferrin level
declines slightly with increasing age,
although it should be noted that one very
high value of 2-46 in the 56-65-year
group affects the mean considerably; the
mean would be 0-96 for the other two cases
if this one male was omitted.
Factors affecting basic level
Blood from patients with malignant
diseases was examined to see whether
factors other than malignancy were affect-
ing caeruloplasmin and Fe transferrin
levels. Several treatments, including
surgery and chemo- and radio-therapy,
were used and analysis of the effects of
individual treatments was complicated by
the use of two or more therapies, often at
the same time on the same patient.
Sampling was only possible on certain
days ofthe week, and hence synchronizing
TABLE I.-Mean Signal Size in Whole
Blood by Age Group (Control Data, ex-
cludingSteroidFemales, ± s.d., n = No.
ofSamples)
Age groups
(years)
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samples
patients
Caeruloplasmin (g = 2-049)
le 1 10 ± 0-287 (n = 25)
nale 1-25 ± 0-295 (n = 32)
th 1-17 ± 0-282 (n = 57)
le 1-07 ± 0-133 (n = 22)
nale 1-29 ± 0-321 (n = 16)
th 1-16 ± 0-255 (n = 38)
le 1-16 ± 0-307 (n = 19)
nale 1-16 ± 0-208 (n = 10)
th 1-16 ± 0-273 (n = 29)
le 1-08 ± 0-214 (n = 14)
nale 1-18 0-165 (n = 8)
th 1412 ± 0-200 (n = 22)
le 1-22 ± 0-204 (n = 6)
nale 1-63 ± 0.390 (n = 5)
th 1-41 ± 0-358 (n = 11)
Fe transferrin (g 4.2)
le 1-16 0-321 (n = 15)
nale 1-06+ 0404 (n = 14)
th 1-11 0-360 (n = 29)
le 1-15 0-264 (n = 13)
nale 1-06 ± 0-502 (n = 8)
th 1-11 i 0-363 (n = 21)
le 1-06 + 0303 (n = 12)
nale 1-19 ± 0-339 (n = 7)
th 1-11 0-314 (n = 19)
le 1-01 0-210 (n = 8)
nale 1-00 ± 0-386 (n = 6)
;h 1-01 0-330 (n = 14)
le 1-49 (n = 3)
nale 0-78 (n = 2)
,h 1-21 (n = 5)
from sufficient numbers of
to obtain a mean value was not
always possible. For this reason many of
the data cannot be pooled and hence, for
some factors, only general conclusions can
be offered.
Nineteen patients were treated surgic-
ally before any other treatment, and
therefore were suitable for studying the
effects of surgery. Fig. 3 shows the
change, by expressing the signal heights as
a percentage of the level measured in the
3 days before treatment. In 5 cases the
caeruloplasmin signal was measured a
week before this "pre-surgical" sample.
The range in these 5 samples was 84 to
124% with a mean of 101% compared to
the appropriate "pre-surgical" sample.
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Fio. 3.-Variation in mean level of whole
blood caeruloplasmin (entire line) and Fe
transferrin (broken line) with time aftei-
surgery, expressed as % of pre-surgical
level. The number of results average(d is
shown at each point.
Although the number of samples on each
day was small, a trend is indicated
towards an increase in caeruloplasmin
level and a decrease in Fe transferrin,
returning to pre-treatment level in about
7 days. This reflects the finding in
individual patients, but as the sample
included a wide range of severities of
operative procedure, from removal of a
small epithelioma on the hand to a
combined radical mastectomy and bilat-
eral oophorectomy, associated in some
cases with transfusion, a considerable
spread of response might be expected and
was found.
Response to chemotherapeutic agents
varied, but in about 25% of cases was
associated with an increase in caerulo-
plasmin signal. Some infections such as
the common cold were not associated with
ESR-detectable changes, but others, in
particular sepsis, elevated the caerulo-
plasmin concentration. Similar elevation
was noted in patients in a terminal phase
of their disease. This high Cu level was
particularly marked in patients with
pulmonary infections. Even in 2 cases
where post mortem examination demon-
strated liver involvement of the malignant
disease there was no decrease in caerulo-
plasmin level of the blood.
Analysis ofpre- and post-treatrment samples
To avoid extraneous effects when
caeruloplasmin and Fe transferrin levels
are studied in malignant disease, all
samples taken during treatment were
disregarded, also those from patients with
infections or in a terminal phase of
disease. For this reason, analysis was only
possible for squamous-cell carcinoma and
breast cancer. Mean values for caerulo-
plasmin and Fe transferrin signal in
samples taken before treatment com-
menced and in the last sample before
discharge, are shown in Table II. Caerulo-
plasmin level is elevated above control
by about the same amount in all groups.
TABLE II.-Peak-to-Peak Heights of
Caeruloplassmin and Fe Transferrin Sig-
nals in Whole Blood in Patients with
Squamous-cell Carcinoma and Breast
CancerBefore and After Treatment. Mean
±s.d. (no samples).
Caeruloplasmin Fe Transferrir
Squamous-cell carcinoma
Pie-treatment 1-52+0-463 (18) 0-78±0-328(10)
Post-treatment 1-57-10-353 (10) 0-77±0*355 (6)
Breast Cancer
Pre-treatment 1-40±0-439 (33) 1-13 -0-508 (24)
Post-treatment 1-55-4-0-387 (14) 0-91 -0-296 (9)
Occasional high values are seen in the pre-
treatment groups, but these are rare, only
8/51 samples having a signal height above
1*75 (the approximate upper limit of
normal) whilst in the post-treatment
group, 9/24 samples were higher than 1 75.
A slight decrease in mean Fe transferrin
was observed, and in this case the effect
was more marked in samples from patients
with squamous-cell carcinoma than with
breast cancer. Once again there is no
significant difference between pre- and
post-treatment samples.
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Bronchial carcinoma was the only other
malignant disease which offered enough
material for examination of pre-treatment
samples, although out of the 6 cases
studied, 2 died within a week of sampling,
and another was possibly entering a
terminal phase of the disease. Eight
samples were examined for caeruloplasmin
level and they showed a mean signal height
of 2 44 + 0 53, the terminal cases averag-
ing 2 60 and the others 2 17, demon-
strating a general increase in caerulo-
plasmin level. The lowest signal height
was 1P75. The Fe transferrin level showed
a slight drop below normal in these
patients (0.83 ± 0 285, n - 5).
GENERAL DISCUSSION AND CONCLUSIONS
Findings of previous workers have been
confirmed as regards a slight sex difference
for caeruloplasmin concentration, and
also a marked increase in the amount of
this protein in the blood of women taking
contraceptive steroids.
From the data so far accumulated, an
upper limit of 1P75 for peak-to-peak
height of caeruloplasmin signal is normal
in controls. This would correspond to a
level of 46 mg of caeruloplasmin per 100
ml of plasma, which is in the upper region
of normal. Average level in plasma is
quoted as 30 mg/100 ml (Miale, 1967),
A solution of purified human caerulo-
plasmin in saline at a concentration of
15 mg/I00 ml yields a peak-to-peak height
of I 12. The values of 1 10 for males and
1 25 for non-steroid females for whole
blood are, therefore, in the expected
range. The lack of difference in Fe trans-
ferrin levels between the sexes also
confirms previous suggestions (e.g. Miale,
1967).
The study of the various factors apart
from malignant disease, which might affect
basic Cu and Fe levels, showed that many
patients might be expected to have
abnormal amounts ofparamagnetic metals
in the blood. Most studies in the past have
been madeusingageneral batch ofpatients
who were unsorted as regards the type of
treatment they were receiving. This is
true ofthe preliminary report ofthis team
(Foster et al., 1973) where elevations in
caeruloplasmin signal were found in
patients with breast cancer when con-
sidered as an unsorted group. The present
study shows that, if only those patients
who are not receiving treatment are
considered, this elevation, although still
present, is very small. Many breast cancer
patients are treated surgically, and it is
possible that by including such patients
in the sample, abnormally high mean
values can be obtained for caeruloplasmin
level.
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